Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancerJoachim Schneider, Hans Hoffmann, Hendrik Dienemann, et al.
The American Journal of Surgical Pathology|March 2, 2016
Clinical Relevance of Different Papillary Growth Patterns of Pulmonary AdenocarcinomaArne Warth, Thomas Muley, Alexander Harms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2013
Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancerThomas Muley, Hendrik Dienemann, Felix J F Herth, et al.
The American Journal of Surgical Pathology|February 28, 2015
Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary AdenocarcinomaArne Warth, Thomas Muley, Claudia A Kossakowski, et al.
Respiratory Research|December 20, 2013
Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patientsNiels Reinmuth, Nadine Payer, Thomas Muley, et al.
The Annals of Thoracic Surgery|October 18, 2011
Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patientsJan op den Winkel, Joachim Pfannschmidt, Thomas Muley, et al.
Scientific Reports|August 7, 2019
Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinomaCarl Maximilian Thielmann, Milene Costa da Silva, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2006
The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cellsIrena Crnković-Mertens, Thomas Muley, Michael Meister, et al.
Clinical Laboratory|January 14, 2012
Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgeryThomas Muley, Markus Kurz, Clemens Männle, et al.
Human Pathology|April 22, 2014
Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancerNiels Reinmuth, Sebastian Kloos, Arne Warth, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancerJoachim Schneider, Hans Hoffmann, Hendrik Dienemann, et al.
The American Journal of Surgical Pathology|March 2, 2016
Clinical Relevance of Different Papillary Growth Patterns of Pulmonary AdenocarcinomaArne Warth, Thomas Muley, Alexander Harms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2013
Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancerThomas Muley, Hendrik Dienemann, Felix J F Herth, et al.
The American Journal of Surgical Pathology|February 28, 2015
Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary AdenocarcinomaArne Warth, Thomas Muley, Claudia A Kossakowski, et al.
Respiratory Research|December 20, 2013
Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patientsNiels Reinmuth, Nadine Payer, Thomas Muley, et al.
The Annals of Thoracic Surgery|October 18, 2011
Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patientsJan op den Winkel, Joachim Pfannschmidt, Thomas Muley, et al.
Scientific Reports|August 7, 2019
Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinomaCarl Maximilian Thielmann, Milene Costa da Silva, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2006
The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cellsIrena Crnković-Mertens, Thomas Muley, Michael Meister, et al.
Clinical Laboratory|January 14, 2012
Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgeryThomas Muley, Markus Kurz, Clemens Männle, et al.
Human Pathology|April 22, 2014
Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancerNiels Reinmuth, Sebastian Kloos, Arne Warth, et al.
Pageof 23